Prospective, multicenter, non-interventional cohort study that will evaluate the Brazilian population with COPD. - SCOPe

Study identifier:D5980R00117

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Prospective Multicentric Cohort Study of Severe and very Severe COPD patients in Brazil.

Medical condition

COPD (Chronic Obstructive Pulmonary Disease)

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

693

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 28 Feb 2025
Estimated Primary Completion Date: 31 Aug 2026
Estimated Study Completion Date: 31 Aug 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria